Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 4(23), p. 259-265, 2023
DOI: 10.1016/j.clml.2023.01.010
Links
Tools
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas
Journal article published in 2023 by
Muhamad Alhaj Moustafa 
,
Bijan J. Borah,
James P. Moriarty,
Ruchita Dholakia,
Liuyan Jiang ,
Ke Li ,
Thomas E. Witzig,
Bradford S. Hoppe,
Jennifer Peterson,
James R. Cerhan,
Han W. Tun
,
Bijan J. Borah,
James P. Moriarty,
Ruchita Dholakia,
Liuyan Jiang ,
Ke Li ,
Thomas E. Witzig,
Bradford S. Hoppe,
Jennifer Peterson,
James R. Cerhan,
Han W. Tun
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 